These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9639464)

  • 1. Use of blue-on-yellow perimetry to demonstrate quadrantanopia in multiple sclerosis.
    Fujimoto N; Adachi-Usami E
    Arch Ophthalmol; 1998 Jun; 116(6):828-9. PubMed ID: 9639464
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-wavelength automated perimetry in neuro-ophthalmologic disorders.
    Keltner JL; Johnson CA
    Arch Ophthalmol; 1995 Apr; 113(4):475-81. PubMed ID: 7710398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual junctional scotoma.
    Milea D; LeHoang P
    Surv Ophthalmol; 2002; 47(6):594-7. PubMed ID: 12504743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):651-6. PubMed ID: 8489448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic visual field disturbances in multiple sclerosis patients without a history of optic neuritis.
    Chorazy M; Drozdowski W; Sherkawey N; Mariak Z
    Neurol Neurochir Pol; 2007; 41(3):223-8. PubMed ID: 17629815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cataract extraction on blue-on-yellow visual field.
    Kim YY; Kim JS; Shin DH; Kim C; Jung HR
    Am J Ophthalmol; 2001 Aug; 132(2):217-20. PubMed ID: 11476682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of achromatic and blue-on-yellow perimetry in patients with resolved central serous chorioretinopathy.
    Afrashi F; Erakgun T; Uzunel D; Mentes J; Kose S; Akkin C
    Ophthalmologica; 2005; 219(4):202-5. PubMed ID: 16088238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):645-50. PubMed ID: 8489447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitemporal visual field defects in presumed multiple sclerosis.
    Sacks JG; Melen O
    JAMA; 1975 Oct; 234(1):69-72. PubMed ID: 1174227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of the visual system in multiple sclerosis].
    Kerty E; Eide N; Nakstad P
    Tidsskr Nor Laegeforen; 1993 May; 113(13):1574-6. PubMed ID: 8337644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency doubling perimetry.
    Sponsel WE; Trigo Y; Hendricks J; Lloyd C
    Am J Ophthalmol; 1998 Jul; 126(1):155-6. PubMed ID: 9683173
    [No Abstract]   [Full Text] [Related]  

  • 12. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervision during automated perimetry.
    Sisto D
    Ophthalmology; 2000 Aug; 107(8):1438-9. PubMed ID: 10919881
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral homonymous visual field defects as initial manifestation of multiple sclerosis.
    Sanchez-Dalmau B; Goñi FJ; Guarro M; Roig C; Duch-Bordas F
    Br J Ophthalmol; 1991 Mar; 75(3):185-7. PubMed ID: 2012791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual field impairment captures disease burden in multiple sclerosis.
    Ortiz-Perez S; Andorra M; Sanchez-Dalmau B; Torres-Torres R; Calbet D; Lampert EJ; Alba-Arbalat S; Guerrero-Zamora AM; Zubizarreta I; Sola-Valls N; Llufriu S; Sepúlveda M; Saiz A; Villoslada P; Martinez-Lapiscina EH
    J Neurol; 2016 Apr; 263(4):695-702. PubMed ID: 26860093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on automated perimetry papers.
    Keltner JL
    Ophthalmology; 1979 Jul; 86(7):1317-9. PubMed ID: 233863
    [No Abstract]   [Full Text] [Related]  

  • 17. Perimetry.
    Ellenberger C
    Int Ophthalmol Clin; 1977; 17(1):85-113. PubMed ID: 844961
    [No Abstract]   [Full Text] [Related]  

  • 18. Threshold perimetry of each eye with both eyes open in patients with monocular functional (nonorganic) and organic vision loss.
    Hoffman DJ; Wilson R
    Am J Ophthalmol; 1999 Feb; 127(2):242-3. PubMed ID: 10030586
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated perimetry in glaucoma--room for improvement?
    O'Brien C; Wild JM
    Br J Ophthalmol; 1995 Mar; 79(3):200-1. PubMed ID: 7703193
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency doubling technology perimetry for detection of glaucomatous visual field loss.
    Brusini P
    Am J Ophthalmol; 2000 Dec; 130(6):860-1. PubMed ID: 11192560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.